Search Results 291-300 of 17449 for what is vedolizumab

1. Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis - Mayo Clinic

   Study to Evaluate the Safety and Efficacy of Two Drug Regimens in Subjects with Moderate to Severe Ulcerative Colitis · More about research at Mayo Clinic · Mayo ...

2. Mayo Clinic Q and A: Treating inflammatory bowel disease

   It is not possible to tell from your question what kind of inflammatory bowel disease you have (ulcerative colitis or Crohn's disease). As the types of surgery ...

3. IBD Biobank Study

   Mayo Clinic's IBD Biobank Study collects biological samples & medical information to advance research on inflammatory bowel disease, Crohn's disease & other ...

4. Digestive Diseases News - Medical Professionals - Mayo Clinic

   New medications have improved pediatric IBD care, but surgery is still an important option to cure ulcerative colitis and reduce Crohn's disease symptoms.

5. A Study to Evaluate Remicade (Infliximab) for the Prevention of Recurrence in Crohn's Disease Patients Undergoing Surgical Resection and are at an Increased Risk of Recurrence - Mayo Clinic

   ... Crohn's disease and may be useful in preventing a relapse of Crohn's disease after surgical resection. Participation eligibility. Participant eligibility ...

6. Ustekinumab-kfce (intravenous route, subcutaneous route) - Mayo Clinic

   Ustekinumab-kfce injection is also used to treat moderate to severe active Crohn's disease and ulcerative colitis. This medicine is available only with your ...

7. Adverse effects related to Heplisav-B vaccination in patients with Inflammatory Bowel Disease - Mayo Clinic

   ... ulcerative colitis or Crohn's disease. This new vaccine has been found to be more effective than the existing vaccine Engerix in people without ulcerative ...

8. An Extension Study Monitoring the Safety of Patients with Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144 - Mayo Clinic

   The purpose of this extension study is to monitor the safety and effectiveness of etrolizumab treatment in patients with moderate to severely active Crohn's ...

9. Diarrhea Causes - Mayo Clinic

   Crohn's disease — which causes tissues in the digestive tract to become inflamed. Inflammatory bowel disease (IBD) · Irritable bowel syndrome — a group of ...

10. A Study to Evaluate the Safety and Effectiveness of Ustekinumab as Initial or Maintenance Therapy for Patients with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... vedolizumab at a dose approved for the treatment of UC and failed to respond to or tolerate such treatment; Is naïve to biologic therapy (TNF antagonists or ...